How are VTRS butterfly max profit and max loss calculated?

Max profit equals the wing width minus net debit times 100 (reached when the underlying pins the middle strike); max loss equals the net debit times 100. Two breakevens at lower-wing plus debit and upper-wing minus debit. For the VTRS butterfly priced from the August 14, 2026 end-of-day chain at a 30-day expiry (ATM IV 26.00%), the computed maximum profit is $94.57 per contract and the computed maximum loss is -$2.50 per contract. Live intraday quotes will differ as the chain moves through the trading session.

What is the breakeven for a VTRS butterfly?

The breakeven for the VTRS butterfly priced on this page is roughly $15.02 and $17.03 at expiration, derived from the August 14, 2026 end-of-day chain's premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The VTRS market-implied 1-standard-deviation expected move in the same options snapshot is approximately 7.45%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.

How does current VTRS implied volatility affect this butterfly?

VTRS ATM IV is at 26.00% with IV rank near 1.75%, which is on the low end of its 1-year range. Premium-buying structures (long call, long put, debit spreads) are relatively cheap in this regime; premium-selling structures collect less credit per unit risk.

VTRS Butterfly Strategy

VTRS (Viatris Inc.), in the Healthcare sector, (Drug Manufacturers - Specialty & Generic industry), listed on NASDAQ.

Viatris Inc. operates as a global pharmaceutical and healthcare enterprise. Its business is structured across four primary geographic divisions: Developed Markets, Greater China, JANZ (Japan, Australia, New Zealand), and Emerging Markets. The company offers a comprehensive range of pharmaceutical products, encompassing branded prescription medications, generic and complex generic drugs, biosimilar treatments, and active pharmaceutical ingredients (APIs). These offerings target diverse therapeutic areas, addressing both noncommunicable and infectious diseases. Its biosimilars specifically focus on critical conditions in oncology, immunology, endocrinology, ophthalmology, and dermatology. Furthermore, Viatris's APIs are utilized across numerous drug categories, including antibacterials, central nervous system agents, antihistamines/antiasthmatics, cardiovascular, antivirals, antidiabetics, antifungals, and proton pump inhibitors.

VTRS (Viatris Inc.) trades in the Healthcare sector, specifically Drug Manufacturers - Specialty & Generic, with a market capitalization of approximately $18.75B, a beta of 0.90 versus the broader market, a 52-week range of 9.43-18.39, average daily share volume of 10.6M, a public-listing history dating back to 1980, approximately 30K full-time employees. These structural characteristics shape how VTRS stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.

A beta of 0.90 places VTRS roughly in line with broader market moves, so the strategy payoff and realized volatility track the index-equivalent baseline. VTRS pays a dividend, which adjusts put-call parity and shifts the ex-dividend pricing across the listed chain.

What is a butterfly on VTRS?

A long call butterfly buys one lower-strike call, sells two ATM calls, and buys one higher-strike call, paying a small net debit for a defined-risk position that maxes out if the underlying pins the middle strike at expiration.

VTRS snapshot

As of August 14, 2026, spot at $16.21, ATM IV 26.00%, IV rank 1.75%, expected move 7.45%. The butterfly on VTRS below is built from the August 14, 2026 end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 154-day expiry.

Why this butterfly structure on VTRS specifically: VTRS IV at 26.00% is on the cheap side of its 1-year range, which favors premium-buying structures like a VTRS butterfly, with a market-implied 1-standard-deviation move of approximately 7.45% (roughly $1.21 on the underlying). The 154-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated VTRS expiries trade a higher absolute premium for lower per-day decay. Position sizing on VTRS should anchor to the underlying notional of $16.21 per share and to the trader's directional view on VTRS stock.

VTRS butterfly setup

The VTRS butterfly below is built from the August 14, 2026 end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With VTRS at $16.21 on that close, the first option leg uses a $15.00 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed VTRS chain at a 154-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 VTRS shares for the stock leg in covered calls and collars).

Action	Type	Strike / Basis	Premium (est)
Buy 1	Call	$15.00	$1.98
Sell 2	Call	$16.00	$1.48
Buy 1	Call	$17.00	$1.00

VTRS butterfly risk and reward

Net Premium / Debit: -$2.50
Max Profit (per contract): $94.57
Max Loss (per contract): -$2.50
Breakeven(s): $15.02, $17.03
Risk / Reward Ratio: 37.828

Max profit equals the wing width minus net debit times 100 (reached when the underlying pins the middle strike); max loss equals the net debit times 100. Two breakevens at lower-wing plus debit and upper-wing minus debit.

VTRS butterfly payoff curve

Modeled P&L at expiration across a range of underlying prices for the butterfly on VTRS. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.

P&L at expiration across the modeled underlying-price range. Green shading marks profitable regions, red shading marks loss regions. Dotted purple verticals mark breakevens; the solid dark vertical marks current spot.

Underlying Price	% From Spot	P&L at Expiration
$0.01	-99.9%	-$2.50
$3.59	-77.8%	-$2.50
$7.18	-55.7%	-$2.50
$10.76	-33.6%	-$2.50
$14.34	-11.5%	-$2.50
$17.93	+10.6%	-$2.50
$21.51	+32.7%	-$2.50
$25.09	+54.8%	-$2.50
$28.67	+76.9%	-$2.50
$32.26	+99.0%	-$2.50

When traders use butterfly on VTRS

Butterflies on VTRS are pinning bets - traders use them when they expect VTRS to settle near a specific level at expiration (often the prior close, a round number, or the max-pain strike) and want defined-risk exposure to that outcome.

VTRS thesis for this butterfly

The market-implied 1-standard-deviation range for VTRS extends from approximately $15.00 on the downside to $17.42 on the upside. A VTRS long call butterfly is a pinning play: it pays maximum at the middle strike if VTRS settles there at expiration, with the wing legs capping both the cost and the maximum loss to the net debit. Current VTRS IV rank near 1.75% sits in the lower third of its 1-year distribution, where IV often re-expands toward the mean; this favors premium-buying structures and disadvantages premium-selling structures on VTRS at 26.00%. As a Healthcare name, VTRS options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to VTRS-specific events.

VTRS butterfly positions are structurally neutral / pin (limited-risk, limited-reward); the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. VTRS positions also carry Healthcare sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move VTRS alongside the broader basket even when VTRS-specific fundamentals are unchanged. Always rebuild the position from current VTRS chain quotes before placing a trade.

Frequently asked questions

What is a butterfly on VTRS?: A butterfly on VTRS is the butterfly strategy applied to VTRS (stock). The strategy is structurally neutral / pin (limited-risk, limited-reward): A long call butterfly buys one lower-strike call, sells two ATM calls, and buys one higher-strike call, paying a small net debit for a defined-risk position that maxes out if the underlying pins the middle strike at expiration. With VTRS stock at $16.21 on the August 14, 2026 close, the strikes shown on this page are snapped to the nearest listed VTRS chain strike and the premiums come straight from that session's bid/ask midpoint.
How are VTRS butterfly max profit and max loss calculated?: Max profit equals the wing width minus net debit times 100 (reached when the underlying pins the middle strike); max loss equals the net debit times 100. Two breakevens at lower-wing plus debit and upper-wing minus debit. For the VTRS butterfly priced from the August 14, 2026 end-of-day chain at a 30-day expiry (ATM IV 26.00%), the computed maximum profit is $94.57 per contract and the computed maximum loss is -$2.50 per contract. Live intraday quotes will differ as the chain moves through the trading session.
What is the breakeven for a VTRS butterfly?: The breakeven for the VTRS butterfly priced on this page is roughly $15.02 and $17.03 at expiration, derived from the August 14, 2026 end-of-day chain's premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The VTRS market-implied 1-standard-deviation expected move in the same options snapshot is approximately 7.45%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
When should you consider a butterfly on VTRS?: Butterflies on VTRS are pinning bets - traders use them when they expect VTRS to settle near a specific level at expiration (often the prior close, a round number, or the max-pain strike) and want defined-risk exposure to that outcome.
How does current VTRS implied volatility affect this butterfly?: VTRS ATM IV is at 26.00% with IV rank near 1.75%, which is on the low end of its 1-year range. Premium-buying structures (long call, long put, debit spreads) are relatively cheap in this regime; premium-selling structures collect less credit per unit risk.